Ilir Agalliu (@AgalliuIlir)

Ilir Agalliu Retweeted

C

Cancers MDPI@Cancers_MDPI · Jul 11

📢Happy to share the #SpecialIssue "#Urological Cancer: #Epidemiology and #Genetics" edited by Dr. Ilir Agalliu & Dr. Evan Kovac, which is open for submissions! 👏 @EinsteinMed @RutgersCancer 🗓️Submission Deadline: 30 June 2026 📌Find more details here: mdpi.com/journal/cancer…

1

2

0

182

I

Ilir Agalliu@AgalliuIlir · Feb 8

NIH cuts billions of dollars in biomedical funding, effective immediately washingtonpost.com/health/2025/02…

AgalliuIlir's tweet card. Researchers say it would hurt facilities that work on medical issues such as cancer research and heart disease. Elon Musk contends the old policy was ‘a ripoff.’

0

38

I

Ilir Agalliu@AgalliuIlir · Feb 8

NIH is lowering indirect costs to 15% on all existing and new grants for all institutions.

NNIH@NIH · Feb 7

Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above…

0

143

Ilir Agalliu Retweeted

N

NIH@NIH · Feb 7

Last year, $9B of the $35B that the National Institutes of Health (NIH) granted for research was used for administrative overhead, what is known as “indirect costs.” Today, NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%, above…

3.0K

7.0K

33.0K

3.0K

29.2M

I

Ilir Agalliu@AgalliuIlir · Jan 14

Cancer Incidence in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) – The Onco-SOL Ancillary Study aacrjournals.org/cebp/article-a…

0

1

0

24

I

Ilir Agalliu@AgalliuIlir · Dec 12

Our meta-analysis comparing the efficacy of various treatments for non-muscle invasive bladder cancer was just published in Cancers mdpi.com/2072-6694/16/2…

0

1

0

34

Ilir Agalliu Retweeted

C

Cancers MDPI@Cancers_MDPI · Jun 15, 2023

🆕A Special Issue “Prostate Cancer Epidemiology and Lifestyle Factors” is open for submissions❗️👏 🔹Guest Editor: Dr. Ilir Agalliu @YUNews👏 ⏰Deadline for manuscript submissions: 1 February 2024. 🔗More details are in the following link: mdpi.com/journal/cancer…

0

1

2

0

2.0K

I

Ilir Agalliu@AgalliuIlir · Sep 11, 2023

As Editor of Cancers Journal, Special Issue on "Prostate Cancer Epidemiology and Lifestyle Factors", I am inviting cancer epidemiologists to contribute their research to this special issue:

CCancers MDPI@Cancers_MDPI · Jun 15, 2023

🆕A Special Issue “Prostate Cancer Epidemiology and Lifestyle Factors” is open for submissions❗️👏 🔹Guest Editor: Dr. Ilir Agalliu @YUNews👏 ⏰Deadline for manuscript submissions: 1 February 2024. 🔗More details are in the following link: mdpi.com/journal/cancer…

0

3

0

817

Ilir Agalliu Retweeted

D

Dr. Jason Vassy@jasonvassy · Nov 10, 2023

Long-awaited multi-ancestry prostate cancer GWAS update is out. —Up to 451 genome-wide hits (minus 51 associated with non-cancer PSA elevation). —The PRS might distinguish risk of aggressive vs. non-aggressive disease in African ancestry men nature.com/articles/s4158…

0

6

32

5

6.0K

I

Ilir Agalliu@AgalliuIlir · Oct 10, 2023

Looking forward to presenting our past and recent work on the role of Wnt / beta-catenin signaling in neurovascular unit maturation at the @vascularbiology 2023 meeting next week!

NNAVBO@vascularbiology · Sep 11, 2023

On the program at Vascular Biology 2023: Dritan Agalliu Associate Prof at Columbia University will present Pleiotropic roles of Wnt/b-catenin signaling in Neurovascular Unit Maturation Lab conta.cc/44NQ5So Details and registration navbo.org/vb2023 #NAVBO2023

0

4

21

0

3.0K

I

Ilir Agalliu@AgalliuIlir · Sep 11, 2023

Looking forward to it!

NNAVBO@vascularbiology · Sep 11, 2023

On the program at Vascular Biology 2023: Dritan Agalliu Associate Prof at Columbia University will present Pleiotropic roles of Wnt/b-catenin signaling in Neurovascular Unit Maturation Lab conta.cc/44NQ5So Details and registration navbo.org/vb2023 #NAVBO2023

0

3

6

0

1.0K

I

Ilir Agalliu@AgalliuIlir · Aug 19, 2023

Congratulations. Excellent work. So happy I could advise on statistical analysis

DDritan Agalliu@DAgalliu · Aug 18, 2023

I’m very excited that the work of @FGarrettiPhD and @ConnorMonahan8 on immune mechanisms driving the gut pathology in prodromal PD is out in @NeuroCellPress. Thanks to the amazing work of the first authors and my collaborator Dave Sulzer! sciencedirect.com/science/articl…

1

0

4

0

308

I

Ilir Agalliu@AgalliuIlir · Jun 17, 2023

Please send your questions that you may have for a chance to answer them at the end of the webinar on 6/29.

PPANDAS PHYSICIANS NETWORK@PANDASPPN · Jun 16, 2023

What PANS/PANDAS research question do you want Dritan Agalliu PhD to answer during the 6/29 webinar? Ask here & it might get answered. Webinar registration: bit.ly/dragalliuwebin… Read the research: shorturl.at/uxTX3 Hosted in partnership by @PANDASPPN & @PANDASnetwork

2

6

12

1

1.0K

Ilir Agalliu Retweeted

B

BCM Department of Neuroscience@bcm_neurosci · Oct 20, 2022

We are excited about @DAgalliu's visit to @bcm_neurosci tomorrow! Join us at 11am CT in N315, Alkek to hear his lecture, "Mechanisms of Angiogenesis and Neurovascular Barrier Development, Breakdown and Repair in the Central Nervous System”. DM for Zoom details. All are welcome!

0

2

8

0

I

Ilir Agalliu@AgalliuIlir · Oct 5, 2022

We are seeking a highly motivated postdoctoral scientist with outstanding training in genetic and cancer epidemiology at Albert Einstein College of Medicine: linkedin.com/jobs/view/3297…

0

1

0